Premarket Development Times for Innovative Vaccines––To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?

One reason expressed in surveys of people reporting coronavirus disease 2019 (COVID-19) vaccine hesitancy is how rapidly these vaccines have reached the market. To estimate the length of time the COVID-19 vaccine spent in research and development as compared to other novel vaccines, we apply previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Beall, Reed F, Kesselheim, Aaron S, Hollis, Aidan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135646/
https://www.ncbi.nlm.nih.gov/pubmed/33914860
http://dx.doi.org/10.1093/cid/ciab389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135646/
https://www.ncbi.nlm.nih.gov/pubmed/33914860
http://dx.doi.org/10.1093/cid/ciab389

Ejemplares similares